Status:
COMPLETED
Effect of S-adenosylmethionine (SAMe) on Blood Levels of Homocysteine
Lead Sponsor:
Baylor Research Institute
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Hyperhomocysteinemia
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The purpose of this study is to investigate whether S-adenosylmethionine (SAMe), a natural substance available as a nutritional supplement, can influence blood levels of homocysteine (Hcy). More speci...
Detailed Description
The purpose of this study is to investigate whether S-adenosylmethionine (SAMe), a natural substance available as a nutritional supplement, can influence blood levels of homocysteine (Hcy). More speci...
Eligibility Criteria
Inclusion
- 18 years of age and older
- Must have a serum homocysteine value greater than or equal to 14 μmol/L
- Stable weight 3 months prior to study participation
Exclusion
- Subjects with a BMI greater than 35 or less than 18
- Currently taking B 100 or other high-dose B vitamin supplements within the past 12 months
- Taken methionine or SAMe supplements within the past 3 months
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT00473200
Start Date
August 1 2009
End Date
July 1 2013
Last Update
March 14 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baylor University Medical Center
Dallas, Texas, United States, 75204